Wordt geladen...
Drugs for HER-2-positive breast cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Livro |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer,
2011
|
| Reeks: | Milestones in Drug Therapy, |
| Onderwerpen: | |
| Online toegang: | https://minerva.ufrj.br/F/?func=direct&doc_number=000895504&local_base=UFR01 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|